Clasificación en acciones
#31262
Noxopharm Limited is an Australian drug development company with an... Noxopharm Limited is an Australian drug development company with an international reach, focused on pioneering new treatment options for a range of solid tumor cancers and septic shock. Its primary asset, Veyonda, functions as an adjuvant therapy designed to augment the effectiveness of chemotherapy and radiotherapy in treating late-stage cancers. Beyond Veyonda, the company's robust development pipeline encompasses several key programs: The DARRT program, currently in Phase 1b/2a clinical trials, is addressing metastatic castration-resistant prostate cancer and other solid tumors. The LuPIN program explores a combined therapy of Veyonda and 177Lu-PSMA-617 for advanced prostate cancer. The IONIC program combines Veyonda with Bristol Myers Squibb's checkpoint inhibitor, Opdivo, targeting various solid tumor types. Its Chemotherapy Enhancement Program (CEP) integrates Veyonda with carboplatin for patients suffering from refractory solid tumors in areas such as the breast, head and neck, lung, prostate, and ovaries. Furthermore, the NOXCOVID Program is conducting a dose escalation and expansion study of NOX66 for the treatment of COVID-19 infection. The company is also investigating potential treatments for pancreatic cancer and glioblastoma. Noxopharm collaborates with the Hudson Institute of Medical Research and The Australian National University on the research and development of therapeutic drugs for inflammatory disorders. Incorporated in 2015, the company's operations are based in Chatswood, Australia.
Precio por acción
$0.04443294
Última sincronización: 2026-09-24
Capitalización bursátil
$13.65M
Comercio Noxopharm Limited (NOX)
Historial de dividendos de Noxopharm Limited (NOX)
Noxopharm Limited (símbolo bursátil: NOX) realizó un total de 0 pagos de dividendos.
La suma de todos los dividendos (ajustados por splits de acciones) es: 0.00
Rentabilidad por dividendo (TTM): 0
Pagos de dividendos de Noxopharm Limited (NOX) desde 2026 hasta 2026
Pagos anuales de dividendos
| Año |
Dividendo (ajustado por splits de acciones) |
Cambiar |
|
Not enough data for the provided dates. |
Lista de todos los pagos de dividendos
| Año |
Dividendo |
Cambiar |
|
Not enough data for the provided dates. |
Pagos de dividendos de empresas similares o competidoras
| Empresa |
Número de pagos de dividendos |
País |
|
|
0.00% |
US
|
|
|
0.00% |
US
|
|
|
64.00% |
AU
|
|
|
0.00% |
NL
|
|
|
0.00% |
CH
|
